PROGENICS PHARMACEUTICALS INC. PGNX (NASDAQ)

$ 7.89
20:09
Sponsored by
Click here!
Change: +0.61 (+8.38%)
Volume: 1,071,200

Avg. Volume: 347055
P/E Ratio: 0
EPS (Annual): -1.54
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 30,450
Institutional Shareholders: 94.92%
Last: 7.89
Change: +0.61 (+8.38%)
Prev. Close: 7.28
Open: 7.27
Day's Range: 7.16 - 8.01
52wk Range: 4.33 - 22.38
Market Value: 282,310
Beta: 2.01
12-month EPS Change: 0.00%
Total Return Last 12 Months: -59.40%
Total Return Last 3 Years: -100.39%
Total Return Last 5 Years: -56.56%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on PGNX
Alert me Subscribe

Unprecedented Bright Spot in Market Downturn

It's Thanksgiving and the markets are taking a well-deserved break. Frankly, they sure could use it. The recent volatility is unprecedented.READ MORE
Nov 28, 2008 2:34PM
Keywords: CLDX, SGMO, PGNX, DNDN

Movers roundup: Warner Music, Assurant

Among the stock activity stories for Wednesday, Nov. 26, from AP Financial News: NEW YORK (AP)--Shares of Warner Music Group Corp. climbed Wednesday after the company's fiscal four...READ MORE
Nov 26, 2008 2:32PM
Keywords: WMG, AIZ, CHS, PGNX

Progenics shares gain ground Relistor study data

(NEW YORK)Shares of Progenics Pharmaceuticals Inc. rose Wednesday after the drug developer and its partner Wyeth said their constipation treatment Relistor was effective in a late-stage stud...READ MORE
Nov 26, 2008 10:56AM
Keywords: PGNX, WYE

Wyeth, Progenics get European constipation drug OK

(NEW YORK)Drug developers Wyeth and Progenics Pharmaceuticals Inc. said Thursday European regulators approved Relistor as a treatment for constipation related to pain drugs taken by terminal...READ MORE
Jul 03, 2008 1:23PM
Keywords: PGNX, WYE

Progenics rises on oral Relistor mid-stage trial data

(NEW YORK)Shares of Progenics Pharmaceuticals Inc. rose Thursday as positive midstage trial results for an oral version of its constipation drug Relistor offset the failure of the drug's...READ MORE
May 22, 2008 6:53PM
Keywords: PGNX, WYE

Progenics rises on oral Relistor mid-stage trial data

(NEW YORK)Shares of Progenics Pharmaceuticals Inc. rose Thursday as positive midstage trial results for an oral version of its constipation drug Relistor offset the failure of the drug's...READ MORE
May 22, 2008 1:54PM
Keywords: PGNX, WYE

Wyeth, Progenics drug misses goal in late-stage trial

(COLLEGEVILLE, Pa.)Wyeth and Progenics Pharmaceuticals Inc. said Thursday that early results from a late-stage trial of their drug Relistor did not meet its goal in restoring gastrointestinal functio...READ MORE
May 22, 2008 9:40AM
Keywords: PGNX, ADLR, WYE
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +7.50 54.64
GILEAD SCIENCES -12.20 44.09
CELGENE CORPORA -20.30 50.84
GENENTECH INC -4.90 71.77
GENZYME CORPORA -24.00 60.04